🇺🇸 FDA
Pipeline program

Oka strain varicella attenuated live vaccine

JSVCT057

Phase 3 mab completed

Quick answer

Oka strain varicella attenuated live vaccine for Chickenpox Vaccines is a Phase 3 program (mab) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Chickenpox Vaccines
Phase
Phase 3
Modality
mab
Status
completed

Clinical trials